002393 力生制药
已收盘 07-11 15:00:00
资讯
新帖
简况
力生制药最新公告:补缴税款3511万元 预计减少2025年净利润
证券之星 · 06-27
力生制药最新公告:补缴税款3511万元 预计减少2025年净利润
肝素概念盘中拉升,力生制药涨1.14%
市场透视 · 06-23
肝素概念盘中拉升,力生制药涨1.14%
力生制药:使用5,000万元购买兴业银行理财产品
公司公告 · 06-19
力生制药:使用5,000万元购买兴业银行理财产品
【天津发展(00882.HK)附属认购5000万元理财产品】智通财经APP讯,天津发展(00882.HK)发布公告,于2
智通财经 · 06-19
【天津发展(00882.HK)附属认购5000万元理财产品】智通财经APP讯,天津发展(00882.HK)发布公告,于2
力生制药(002393)6月10日股东户数2.14万户,较上期增加39.99%
证券之星 · 06-16
力生制药(002393)6月10日股东户数2.14万户,较上期增加39.99%
力生制药:公司在创新药研发方面积极布局通过实施“内生外引”战略推进业务发展
证券之星 · 06-16
力生制药:公司在创新药研发方面积极布局通过实施“内生外引”战略推进业务发展
每周股票复盘:力生制药(002393)使用闲置资金及募集资金购买理财产品
证券之星 · 06-13
每周股票复盘:力生制药(002393)使用闲置资金及募集资金购买理财产品
异动快报:力生制药(002393)6月13日13点2分触及涨停板
证券之星 · 06-13
异动快报:力生制药(002393)6月13日13点2分触及涨停板
天津中医药大学第一附属医院中标天津力生制药员工健康体检项目
DoNews · 06-12
天津中医药大学第一附属医院中标天津力生制药员工健康体检项目
天津发展(00882)附属力生制药认购兴业银行理财产品
智通财经 · 06-11
天津发展(00882)附属力生制药认购兴业银行理财产品
力生制药:使用5000万元闲置资金购买兴业银行理财产品
公司公告 · 06-11
力生制药:使用5000万元闲置资金购买兴业银行理财产品
每周股票复盘:力生制药(002393)将举办2024年度网上业绩说明会
证券之星 · 05-30
每周股票复盘:力生制药(002393)将举办2024年度网上业绩说明会
5月29日力生制药(002393)涨停分析:研发突破、分红利好、政策评级驱动
证券之星 · 05-29
5月29日力生制药(002393)涨停分析:研发突破、分红利好、政策评级驱动
开源证券给予力生制药买入评级:全资子公司获分红超3亿,夯实科改示范企业地位
每日经济新闻 · 05-22
开源证券给予力生制药买入评级:全资子公司获分红超3亿,夯实科改示范企业地位
“产业+资本”双轮战略喜丰收 力生制药子公司获天士力生物超3亿元现金分红
全景网 · 05-22
“产业+资本”双轮战略喜丰收 力生制药子公司获天士力生物超3亿元现金分红
力生制药:全资子公司中央药业获天士力生物现金分红3.038亿元
公司公告 · 05-21
力生制药:全资子公司中央药业获天士力生物现金分红3.038亿元
天津发展(00882):力生制药一季度归母净利润5527.53万元 同比减少6.56%
智通财经 · 04-25
天津发展(00882):力生制药一季度归母净利润5527.53万元 同比减少6.56%
图解力生制药一季报:第一季度单季净利润同比减6.56%
证券之星 · 04-24
图解力生制药一季报:第一季度单季净利润同比减6.56%
力生制药(002393.SZ)发布一季度业绩,归母净利润5527.53万元,同比下降6.56%
智通财经 · 04-24
力生制药(002393.SZ)发布一季度业绩,归母净利润5527.53万元,同比下降6.56%
每周股票复盘:力生制药(002393)股东户数减少1518户,户均持股增至1.68万股
证券之星 · 04-18
每周股票复盘:力生制药(002393)股东户数减少1518户,户均持股增至1.68万股
加载更多
公司概况
公司名称:
天津力生制药股份有限公司
所属行业:
医药制造业
上市日期:
2010-04-23
主营业务:
天津力生制药股份有限公司的主营业务是医药产品研发、生产和销售。公司的主要产品是寿比山®吲达帕胺片、三鱼®氨酚咖匹林片、希福尼®头孢地尼分散片、友好®麻仁软胶囊、生化®氢化可的松琥铂酸钠冻干粉针和碳酸氢钠片、盖胃平片、麻仁润肠丸、虎力散片等。力生制药“三鱼”商标成功入选了由中华人民共和国商务部等五部委联合认定的第三批中华老字号名单。
发行价格:
45.00
{"stockData":{"symbol":"002393","market":"SZ","secType":"STK","nameCN":"力生制药","latestPrice":19.41,"timestamp":1752217413000,"preClose":19.4,"halted":0,"volume":5624060,"delay":0,"changeRate":0.0005,"floatShares":250000000,"shares":258000000,"eps":0.701,"marketStatus":"已收盘","change":0.01,"latestTime":"07-11 15:00:00","open":19.4,"high":19.66,"low":19.39,"amount":110000000,"amplitude":0.0139,"askPrice":19.42,"askSize":385,"bidPrice":19.41,"bidSize":118,"shortable":0,"etf":0,"ttmEps":0.701,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1752456600000},"marketStatusCode":5,"adr":0,"adjPreClose":19.4,"symbolType":"stock","openAndCloseTimeList":[[1752197400000,1752204600000],[1752210000000,1752217200000]],"highLimit":21.34,"lowLimit":17.46,"ibTradeSell":true,"ibTradeBuySell":false,"totalEquity":257704999,"isCdr":false,"pbRate":1.04,"roa":"--","peRate":27.689016,"roe":"1.14%","epsLYR":0.72,"committee":-0.274262,"marketValue":5002000000,"turnoverRate":0.0225,"status":0,"floatMarketCap":4859000000},"requestUrl":"/m/hq/s/002393","defaultTab":"news","newsList":[{"id":"2546379049","title":"力生制药最新公告:补缴税款3511万元 预计减少2025年净利润","url":"https://stock-news.laohu8.com/highlight/detail?id=2546379049","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546379049?lang=zh_cn&edition=full","pubTime":"2025-06-27 16:28","pubTimestamp":1751012917,"startTime":"0","endTime":"0","summary":"力生制药(002393.SZ)公告称,公司根据税务检查和自查情况,需补缴税款及滞纳金共计约3511万元。其中,需补缴所得税及滞纳金3088万元,需补缴增值税及滞纳金423万元。本次不涉及行政处罚。税款及滞纳金已全部缴纳完毕。补缴的税款及滞纳金将计入2025年当期损益,预计将减少公司2025年度归属于上市公司股东的净利润3511万元。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025062700026715.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002393"],"gpt_icon":0},{"id":"2545450661","title":"肝素概念盘中拉升,力生制药涨1.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2545450661","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545450661?lang=zh_cn&edition=full","pubTime":"2025-06-23 09:43","pubTimestamp":1750642995,"startTime":"0","endTime":"0","summary":"06月23日,肝素概念盘中拉升,截至09点43分,肝素概念整体指数上涨0.60%,报965.440点。从个股上来看,该概念的成分股中,力生制药涨1.14%,东诚药业、复星医药、丰原药业涨幅居前。从资金上来看,截止发稿,肝素概念主力净流入为-5073.68万,其中千红制药受到资金热捧,主力净流入350.84万;拉长时间线来看,该板块近20日主力资金净流入-22.55亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025062309431595274b52&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025062309431595274b52&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0096","002393","BK0188","BK0028","BK0060","600196","BK0175","BK0187","BK0196","BK0239","BK0012","BK0183"],"gpt_icon":0},{"id":"2544160246","title":"力生制药:使用5,000万元购买兴业银行理财产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2544160246","media":"公司公告","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544160246?lang=zh_cn&edition=full","pubTime":"2025-06-19 23:00","pubTimestamp":1750345230,"startTime":"0","endTime":"0","summary":"力生制药公告,公司以自有资金5,000万元人民币购买了 兴业银行 发行的“悦享E款第17期”固收类理财产品,风险等级为R2(较低风险),产品期限最短为90天(上下浮动不超过10天),预期年化收益率约为2.2%左右。该现金管理行为旨在提高闲置资金使用效率,不会影响公司日常运营和主营业务发展。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250619230815a4b2e1ca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250619230815a4b2e1ca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1328615791.USD","LU1781817850.SGD","BK0012","601166","LU0572940350.SGD","BK0239","BK0278","LU0821914370.USD","BK0028","BK0187","LU0572939691.SGD","LU0264606111.USD","BK0183","BK0188","002393","LU1048596156.SGD","LU1580142542.USD","BK0015"],"gpt_icon":0},{"id":"2544166023","title":"【天津发展(00882.HK)附属认购5000万元理财产品】智通财经APP讯,天津发展(00882.HK)发布公告,于2","url":"https://stock-news.laohu8.com/highlight/detail?id=2544166023","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544166023?lang=zh_cn&edition=full","pubTime":"2025-06-19 19:25","pubTimestamp":1750332357,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK0012","LU0821914370.USD","BK0187","BK0188","LU0572939691.SGD","LU1048596156.SGD","002393","BK0028","MCNHmain","BK0278","BK1232","CYB","LU1580142542.USD","601166","MUCmain","BK0015","LU1328615791.USD","CNHmain","LU0264606111.USD","LU0572940350.SGD","BK0239","BK0183","00882","UCmain","LU1781817850.SGD"],"gpt_icon":0},{"id":"2543622540","title":"力生制药(002393)6月10日股东户数2.14万户,较上期增加39.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2543622540","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543622540?lang=zh_cn&edition=full","pubTime":"2025-06-16 17:11","pubTimestamp":1750065107,"startTime":"0","endTime":"0","summary":"证券之星消息,近日力生制药披露,截至2025年6月10日公司股东户数为2.14万户,较4月11日增加6120.0户,增幅为39.99%。在化学制药行业个股中,力生制药股东户数低于行业平均水平,截至6月10日,化学制药行业平均股东户数为3.25万户。从股价来看,2025年4月11日至2025年6月10日,力生制药区间涨幅为27.76%,在此期间股东户数增加6120.0户,增幅为39.99%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025061600021076.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0239","002393","BK0028"],"gpt_icon":0},{"id":"2543623824","title":"力生制药:公司在创新药研发方面积极布局通过实施“内生外引”战略推进业务发展","url":"https://stock-news.laohu8.com/highlight/detail?id=2543623824","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543623824?lang=zh_cn&edition=full","pubTime":"2025-06-16 15:06","pubTimestamp":1750057583,"startTime":"0","endTime":"0","summary":"证券之星消息,力生制药06月16日在投资者关系平台上答复投资者关心的问题。力生制药回复:投资者您好,截止2025年6月10日公司股东人数为21424。公司在创新药研发方面积极布局,通过实施“内生外引”战略,采取自主研发、合作开发、许可引进及CMO孵化等多元化模式,推进高端仿制药、创新药、合成生物学、细胞与基因治疗等领域的业务发展,致力于向更高价值链延伸。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025061600012551.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1161","002393","159992","06978","BK0239","BK0028","BK0188","BK1574"],"gpt_icon":0},{"id":"2543342316","title":"每周股票复盘:力生制药(002393)使用闲置资金及募集资金购买理财产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2543342316","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543342316?lang=zh_cn&edition=full","pubTime":"2025-06-14 02:51","pubTimestamp":1749840692,"startTime":"0","endTime":"0","summary":"截至2025年6月13日收盘,力生制药报收于22.11元,较上周的19.43元上涨13.79%。截至本公告日,公司使用闲置自有资金购买理财产品尚未到期的金额共计人民币63900万元,未超过股东大会授权额度。关于使用闲置募集资金进行现金管理的进展公告公司于2025年3月19日召开第七届董事会第五十次会议、2025年4月11日召开2024年度股东大会,审议通过了使用不超过人民币6亿元闲置募集资金购买安全性高、流动性好的短期理财产品,期限不超过12个月。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025061400005330.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0188","002393","BK0028"],"gpt_icon":0},{"id":"2543571581","title":"异动快报:力生制药(002393)6月13日13点2分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2543571581","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543571581?lang=zh_cn&edition=full","pubTime":"2025-06-13 13:05","pubTimestamp":1749791127,"startTime":"0","endTime":"0","summary":"证券之星6月13日盘中消息,13点2分力生制药触及涨停板。目前价格22.11,上涨10.0%。其所属行业化学制药目前下跌。领涨股为永安药业。该股为天津国企改革,新冠药物,国企改革概念热股,当日天津国企改革概念上涨0.51%。6月13日的资金流向数据方面,主力资金净流入2310.43万元,占总成交额6.97%,游资资金净流出1053.56万元,占总成交额3.18%,散户资金净流出1256.87万元,占总成交额3.79%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025061300016128.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002393","BK0028","BK0188","BK0239"],"gpt_icon":0},{"id":"2543528880","title":"天津中医药大学第一附属医院中标天津力生制药员工健康体检项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2543528880","media":"DoNews","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543528880?lang=zh_cn&edition=full","pubTime":"2025-06-13 05:30","pubTimestamp":1749763803,"startTime":"0","endTime":"0","summary":"天眼查App显示,2025年06月11日,天津力生制药股份有限公司发布的员工健康体检成交结果公示显示,天津中医药大学第一附属医院成功中标该项目。中标金额为434054.00元。此次招标的公告类型为中标结果,开标时间为2025年06月09日14时0分,服务期为2025年8月1日至2025年8月31日。同时,推荐的中标候选人为第一名:天津中医药大学第一附属医院,第二名:天津美年投资管理有限公司友谊路门诊部。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613053057977d24b9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613053057977d24b9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0188","002393","562390","561510","BK0239","BK0028"],"gpt_icon":0},{"id":"2542858686","title":"天津发展(00882)附属力生制药认购兴业银行理财产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2542858686","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542858686?lang=zh_cn&edition=full","pubTime":"2025-06-11 19:00","pubTimestamp":1749639601,"startTime":"0","endTime":"0","summary":"智通财经APP讯,天津发展 发布公告,于2025年3月31日至2025年6月11日期间,力生制药已订立以下兴业银行理财协议,以本金总额人民币1.85亿元认购若干投资产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1304053.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0187","BK1232","BK0028","LU0264606111.USD","BK0188","BK0183","00882","002393","LU1048596156.SGD","BK0239","BK0012","LU1580142542.USD","LU0821914370.USD","LU0572940350.SGD","LU1328615791.USD","BK0015","LU1781817850.SGD","601166","BK0278","LU0572939691.SGD"],"gpt_icon":0},{"id":"2542301360","title":"力生制药:使用5000万元闲置资金购买兴业银行理财产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2542301360","media":"公司公告","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542301360?lang=zh_cn&edition=full","pubTime":"2025-06-11 16:37","pubTimestamp":1749631037,"startTime":"0","endTime":"0","summary":"力生制药公告,公司于2025年6月11日以自有资金共计5,000万元人民币在 兴业银行 购买两款固收类理财产品,风险等级为R2,预期年化收益率分别为约2%和2.2%。本次现金管理是在确保日常运营和资金安全前提下进行,旨在提高资金使用效率并获得一定投资收益。此外,公告还披露了过去12个月内公司使用闲置资金购买的其他理财产品情况。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611170014a7036641&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611170014a7036641&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","002393","LU0264606111.USD","LU1781817850.SGD","LU1328615791.USD","BK0012","LU1580142542.USD","BK0187","BK0028","BK0278","601166","BK0183","BK0188","LU0572939691.SGD","LU0821914370.USD","BK0015","LU0572940350.SGD","LU1048596156.SGD"],"gpt_icon":0},{"id":"2539203572","title":"每周股票复盘:力生制药(002393)将举办2024年度网上业绩说明会","url":"https://stock-news.laohu8.com/highlight/detail?id=2539203572","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539203572?lang=zh_cn&edition=full","pubTime":"2025-05-31 05:07","pubTimestamp":1748639235,"startTime":"0","endTime":"0","summary":"截至2025年5月30日收盘,力生制药报收于20.02元,较上周的17.53元上涨14.2%。本周,力生制药5月30日盘中最高价报21.08元,股价触及近一年最高点。本周关注点公司公告汇总:力生制药将于2025年06月04日举办2024年度业绩说明会公司公告汇总力生制药将于2025年06月04日下午15:00~17:00在全景网举办2024年度业绩说明会,采用网络远程方式。天津力生制药股份有限公司董事会2025年05月27日。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025053100006238.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0028","002393","BK0239"],"gpt_icon":0},{"id":"2539239794","title":"5月29日力生制药(002393)涨停分析:研发突破、分红利好、政策评级驱动","url":"https://stock-news.laohu8.com/highlight/detail?id=2539239794","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539239794?lang=zh_cn&edition=full","pubTime":"2025-05-29 15:41","pubTimestamp":1748504463,"startTime":"0","endTime":"0","summary":"证券之星消息,力生制药5月29日涨停收盘,收盘价19.46元。该股于9点51分涨停,未打开涨停,截止收盘封单资金为3555.67万元,占其流通市值0.73%。5月29日的资金流向数据方面,主力资金净流入6604.42万元,占总成交额34.23%,游资资金净流出4072.63万元,占总成交额21.11%,散户资金净流出2531.79万元,占总成交额13.12%。近5日资金流向一览见下表:该股为新冠药物,医药,阿尔茨海默病概念热股,当日新冠药物概念上涨2.87%,医药概念上涨2.74%,阿尔茨海默病概念上涨2.59%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025052900018600.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002393"],"gpt_icon":0},{"id":"2537960780","title":"开源证券给予力生制药买入评级:全资子公司获分红超3亿,夯实科改示范企业地位","url":"https://stock-news.laohu8.com/highlight/detail?id=2537960780","media":"每日经济新闻","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537960780?lang=zh_cn&edition=full","pubTime":"2025-05-22 11:45","pubTimestamp":1747885500,"startTime":"0","endTime":"0","summary":"炒股就看金麒麟分析师研报,权威,专业,及时,全面,助您挖掘潜力主题机会! 开源证券05月21日发布研报称,给予力生制药(002393.SZ,最新价:17.52元)买入评级。评级理由主要包括:1)全资子公司获现金分红超3亿,进一步夯实公司科改示范企业地位;2)公司持续优化布局,产品集群贡献稳定收入。风险提示:行业政策变化风险、新药研发风险、原材料供应和价格波动风险等。(文章来源:每日经济新闻)\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2025-05-22/doc-inexmhcc5089071.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-05-22/doc-inexmhcc5089071.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["161027","002393"],"gpt_icon":0},{"id":"2537882961","title":"“产业+资本”双轮战略喜丰收 力生制药子公司获天士力生物超3亿元现金分红","url":"https://stock-news.laohu8.com/highlight/detail?id=2537882961","media":"全景网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537882961?lang=zh_cn&edition=full","pubTime":"2025-05-22 09:56","pubTimestamp":1747878960,"startTime":"0","endTime":"0","summary":"中央药业依据其持有天士力生物 12.15% 的股份比例,将获得现金分红款 3.04亿元。中央药业对天士力生物的投资可追溯至2018年,彼时,力生制药通过旗下子公司参与天士力生物Pre-IPO轮融资,以战略投资方式切入创新生物药领域。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052209582194fe8dab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052209582194fe8dab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0196","BK0188","600535","BK0183","BK0012","002393","BK0239","BK0028"],"gpt_icon":0},{"id":"2537898634","title":"力生制药:全资子公司中央药业获天士力生物现金分红3.038亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2537898634","media":"公司公告","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537898634?lang=zh_cn&edition=full","pubTime":"2025-05-21 17:20","pubTimestamp":1747819217,"startTime":"0","endTime":"0","summary":"力生制药公告,其全资子公司中央药业按持股12.15%比例将获参股公司 天士力 生物现金分红款3.038亿元,计入2025年度投资收益,对公司业绩产生积极影响,具体数据以审计为准。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250521173017a6e73712&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250521173017a6e73712&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0196","600535","002393","BK0183","BK0239","BK0012","BK0028","BK0188"],"gpt_icon":0},{"id":"2530477089","title":"天津发展(00882):力生制药一季度归母净利润5527.53万元 同比减少6.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530477089","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530477089?lang=zh_cn&edition=full","pubTime":"2025-04-25 12:24","pubTimestamp":1745555044,"startTime":"0","endTime":"0","summary":"智通财经APP讯,天津发展(00882)发布力生制药截至2025年3月31日止3个月业绩,营业总收入3.7亿元人民币,同比增加1.37%;归属于母公司所有者的净利润5527.53万元,同比减少6.56%;每股基本收益0.21元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1284707.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["002393","00882"],"gpt_icon":0},{"id":"2530296575","title":"图解力生制药一季报:第一季度单季净利润同比减6.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530296575","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530296575?lang=zh_cn&edition=full","pubTime":"2025-04-25 01:54","pubTimestamp":1745517293,"startTime":"0","endTime":"0","summary":"证券之星消息,力生制药2025年一季报显示,公司主营收入3.7亿元,同比上升1.37%;归母净利润5527.53万元,同比下降6.56%;扣非净利润5331.08万元,同比下降9.45%;负债率16.39%,投资收益109.28万元,财务费用-2922.77万元,毛利率58.01%。财报数据概要请见下图:以上内容为证券之星据公开信息整理,由智能算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042500001210.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002393"],"gpt_icon":0},{"id":"2529960638","title":"力生制药(002393.SZ)发布一季度业绩,归母净利润5527.53万元,同比下降6.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529960638","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529960638?lang=zh_cn&edition=full","pubTime":"2025-04-24 18:16","pubTimestamp":1745489797,"startTime":"0","endTime":"0","summary":"智通财经APP讯,力生制药(002393.SZ)发布2025年一季度报告,第一季度,公司实现营业收入3.7亿元,同比增长1.37%。归属于上市公司股东的净利润5527.53万元,同比下降6.56%。归属于上市公司股东的扣除非经常性损益的净利润5331.08万元,同比下降9.45%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1284091.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["002393"],"gpt_icon":0},{"id":"2528142220","title":"每周股票复盘:力生制药(002393)股东户数减少1518户,户均持股增至1.68万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2528142220","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528142220?lang=zh_cn&edition=full","pubTime":"2025-04-19 05:14","pubTimestamp":1745010855,"startTime":"0","endTime":"0","summary":"截至2025年4月18日收盘,力生制药报收于16.13元,较上周的15.93元上涨1.26%。本周,力生制药4月18日盘中最高价报16.47元。本周关注点股本股东变化:截至2025年4月11日公司股东户数为1.53万户,较2月28日减少1518.0户,减幅为9.02%股本股东变化近日力生制药披露,截至2025年4月11日公司股东户数为1.53万户,较2月28日减少1518.0户,减幅为9.02%。户均持股数量由上期的1.53万股增加至1.68万股,户均持股市值为26.82万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025041900007072.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002393","BK0028","BK0188"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1752231111000,"stockEarnings":[{"period":"1week","weight":-0.0072},{"period":"1month","weight":-0.0261},{"period":"3month","weight":0.244},{"period":"6month","weight":0.1974},{"period":"1year","weight":0.2977},{"period":"ytd","weight":0.1234}],"compareEarnings":[{"period":"1week","weight":0.014},{"period":"1month","weight":0.0369},{"period":"3month","weight":0.0838},{"period":"6month","weight":0.1077},{"period":"1year","weight":0.194},{"period":"ytd","weight":0.0471}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"天津力生制药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"21424人(较上一季度增加39.99%)","perCapita":"11684股","listingDate":"2010-04-23","address":"天津市西青区西青经济技术开发区赛达北一道16号","registeredCapital":"25770万元","survey":" 天津力生制药股份有限公司的主营业务是医药产品研发、生产和销售。公司的主要产品是寿比山®吲达帕胺片、三鱼®氨酚咖匹林片、希福尼®头孢地尼分散片、友好®麻仁软胶囊、生化®氢化可的松琥铂酸钠冻干粉针和碳酸氢钠片、盖胃平片、麻仁润肠丸、虎力散片等。力生制药“三鱼”商标成功入选了由中华人民共和国商务部等五部委联合认定的第三批中华老字号名单。","listedPrice":45},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"力生制药(002393)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供力生制药(002393)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"力生制药,002393,力生制药股票,力生制药股票老虎,力生制药股票老虎国际,力生制药行情,力生制药股票行情,力生制药股价,力生制药股市,力生制药股票价格,力生制药股票交易,力生制药股票购买,力生制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"力生制药(002393)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供力生制药(002393)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}